These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8289991)

  • 21. Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
    Desager JP; Horsmans Y
    Clin Pharmacokinet; 1996 Nov; 31(5):348-71. PubMed ID: 9118584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacokinetics and practical applications of simvastatin.
    Mauro VF
    Clin Pharmacokinet; 1993 Mar; 24(3):195-202. PubMed ID: 8343198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients.
    Mück W; Mai I; Fritsche L; Ochmann K; Rohde G; Unger S; Johne A; Bauer S; Budde K; Roots I; Neumayer HH; Kuhlmann J
    Clin Pharmacol Ther; 1999 Mar; 65(3):251-61. PubMed ID: 10096257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans.
    Pentikainen PJ; Saraheimo M; Schwartz JI; Amin RD; Schwartz MS; Brunner-Ferber F; Rogers JD
    J Clin Pharmacol; 1992 Feb; 32(2):136-40. PubMed ID: 1613123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Aoki T; Nishimura H; Nakagawa S; Kojima J; Suzuki H; Tamaki T; Wada Y; Yokoo N; Sato F; Kimata H; Kitahara M; Toyoda K; Sakashita M; Saito Y
    Arzneimittelforschung; 1997 Aug; 47(8):904-9. PubMed ID: 9296275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Rogers JD; Zhao J; Liu L; Amin RD; Gagliano KD; Porras AG; Blum RA; Wilson MF; Stepanavage M; Vega JM
    Clin Pharmacol Ther; 1999 Oct; 66(4):358-66. PubMed ID: 10546919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin.
    Watts GF; Castelluccio C; Rice-Evans C; Taub NA; Baum H; Quinn PJ
    J Clin Pathol; 1993 Nov; 46(11):1055-7. PubMed ID: 8254097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Myopathy caused by inhibitors of hydroxymethylglutaryl-coenzyme A reductase].
    Martinez-García FA; Martín-Fernández J; Moltó JM; Villaverde R; Morales A; Fernández-Barreiro A
    Rev Neurol; 1997 Jun; 25(142):869-71. PubMed ID: 9244616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HMG-CoA reductase inhibitor treatment in renal insufficiency.
    Wanner C
    Nephrol Dial Transplant; 1996 Oct; 11(10):1951-2. PubMed ID: 8918704
    [No Abstract]   [Full Text] [Related]  

  • 30. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin and the human lens. Clinical results of a 3-year follow-up.
    Behrens-Baumann W; Thiery J; Wieland E; Fieseler HG; Seidel D
    Arzneimittelforschung; 1992 Aug; 42(8):1023-4. PubMed ID: 1418074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 6-month trial of simvastatin (HMG-CoA reductase inhibitor) in the treatment of hypercholesterolaemia.
    Steyn K; Weich HF; Vermaak WJ; Marais AD; Omar MA; Van Gelder AL; Fourie J; Kotze TJ; Stander I; Firth JC
    S Afr Med J; 1991 Jun; 79(11):639-45. PubMed ID: 2047945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhabdomyolysis with simvastatin use.
    Berland Y; Vacher Coponat H; Durand C; Baz M; Laugier R; Musso JL
    Nephron; 1991; 57(3):365-6. PubMed ID: 2017280
    [No Abstract]   [Full Text] [Related]  

  • 33. Enhancement of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor efficacy through administration of a controlled-porosity osmotic pump dosage form.
    McClelland GA; Stubbs RJ; Fix JA; Pogany SA; Zentner GM
    Pharm Res; 1991 Jul; 8(7):873-6. PubMed ID: 1924137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preventive effect of simvastatin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis in cholesterol-fed rabbits].
    Oogushi K
    Fukuoka Igaku Zasshi; 1991 Feb; 82(2):36-47. PubMed ID: 2022360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical changes and morphological alterations of liver and kidney in hamsters after administration of the HMG-coenzyme A reductase inhibitor, simvastatin: prevention and reversibility by mevalonate.
    Oms P; Assie N; Bruniquel F; Degryse AD; van Haverbeke G; Delhon A
    Pharmacol Toxicol; 1995 Dec; 77(6):391-6. PubMed ID: 8835365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe rhabdomyolysis associated with concurrent use of simvastatin and sirolimus after cisplatin-based chemotherapy in a kidney transplant recipient.
    Hong YA; Kim HD; Jo K; Park YK; Lee J; Sun IO; Chung BH; Park CW; Yang CW; Choi BS
    Exp Clin Transplant; 2014 Apr; 12(2):152-5. PubMed ID: 23734754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of the inhibitors of 3-hydroxy-3-methylglutaryl coenzyme-A reductase, pravastatin and simvastatin, on colony formation by hematopoietic progenitor cells].
    Kunitama M; Komatsu N; Miura Y
    Rinsho Ketsueki; 1996 Nov; 37(11):1314-7. PubMed ID: 8960668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up].
    Wenke K; Thiery J; Meiser B; Arndtz N; Seidel D; Reichart B
    Z Kardiol; 1995 Feb; 84(2):130-6. PubMed ID: 7717016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins.
    Escobales N; Crespo MJ; Altieri PI; Furilla RA
    J Hypertens; 1996 Jan; 14(1):115-21. PubMed ID: 12013483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of lovastatin, an HMG CoA reductase inhibitor, on acute renal allograft rejection.
    Sahu K; Sharma R; Gupta A; Gulati S; Agarwal D; Kumar A; Bhandari M
    Clin Transplant; 2001 Jun; 15(3):173-5. PubMed ID: 11389707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.